Published in Exp Lung Res on December 01, 2000
Chronic immune activation and inflammation as the cause of malignancy. Br J Cancer (2001) 2.26
COX-2 and cancer: a new approach to an old problem. Br J Pharmacol (2001) 1.02
Aspirin use and lung cancer in men. Br J Cancer (2003) 0.95
Crosstalk of oncogenic and prostanoid signaling pathways. J Cancer Res Clin Oncol (2004) 0.92
NNK-Induced Lung Tumors: A Review of Animal Model. J Oncol (2011) 0.89
Cyclooxygenase-2 blockade can improve efficacy of VEGF-targeting drugs. Oncotarget (2015) 0.82
Overview of the molecular carcinogenesis of mouse lung tumor models of human lung cancer. Toxicol Pathol (2007) 0.82
Chemoprevention of lung cancer: prospects and disappointments in human clinical trials. Cancers (Basel) (2013) 0.78
The relationship between stage 1 and 2 non-small cell lung cancer and lung function in men and women. BMC Pulm Med (2006) 0.77
Disruption of tumour-host communication by downregulation of LFA-1 reduces COX-2 and e-NOS expression and inhibits brain metastasis growth. Oncotarget (2016) 0.75
Wildtype Kras2 can inhibit lung carcinogenesis in mice. Nat Genet (2001) 3.27
A major lung cancer susceptibility locus maps to chromosome 6q23-25. Am J Hum Genet (2004) 3.05
Ossifying fibromas of the jaw bone: 20 cases. Dentomaxillofac Radiol (2010) 2.15
Establishment and characterization of SV40 T-antigen immortalized human esophageal epithelial cells. Cancer Res (1991) 1.88
Arginine deprivation as a targeted therapy for cancer. Curr Pharm Des (2008) 1.82
Risk of miscarriage and a common variant of the estrogen receptor gene. Am J Epidemiol (1993) 1.39
Cytotoxicity, sister-chromatid exchanges and DNA single-strand breaks induced by 4-oxo-4-(3-pyridyl)butanal, a metabolite of a tobacco-specific N-nitrosamine. Mutat Res (1990) 1.39
Cancer chemopreventive potential of sulforamate, a novel analogue of sulforaphane that induces phase 2 drug-metabolizing enzymes. Cancer Res (1997) 1.36
Gene expression signatures identify novel regulatory pathways during murine lung development: implications for lung tumorigenesis. J Med Genet (2003) 1.31
Identification of candidate lung cancer susceptibility genes in mouse using oligonucleotide arrays. J Med Genet (2002) 1.23
Prevention of NNK-induced lung tumorigenesis in A/J mice by acetylsalicylic acid and NS-398. Cancer Res (1998) 1.22
Arginine deprivation, autophagy, apoptosis (AAA) for the treatment of melanoma. Curr Mol Med (2010) 1.21
Effects of alpha-deuterium substitution on the mutagenicity of 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Carcinogenesis (1983) 1.18
Synergistic activation of MAP kinase (ERK1/2) by erythropoietin and stem cell factor is essential for expanded erythropoiesis. Blood (1998) 1.18
Activation of mitogen-activated protein (MAP) kinase pathway by pervanadate, a potent inhibitor of tyrosine phosphatases. J Biol Chem (1996) 1.14
Chemopreventive efficacies of aspirin and sulindac against lung tumorigenesis in A/J mice. Carcinogenesis (1997) 1.12
The cyclooxygenase inhibitor ibuprofen and the FLAP inhibitor MK886 inhibit pancreatic carcinogenesis induced in hamsters by transplacental exposure to ethanol and the tobacco carcinogen NNK. J Cancer Res Clin Oncol (2002) 1.09
Inhibitors of lipoxygenase: a new class of cancer chemopreventive agents. Carcinogenesis (1998) 1.09
A germ-line p53 mutation accelerates pulmonary tumorigenesis: p53-independent efficacy of chemopreventive agents green tea or dexamethasone/myo-inositol and chemotherapeutic agents taxol or adriamycin. Cancer Res (2000) 1.07
Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase. Br J Cancer (2012) 1.06
On the formation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone during smoking. Cancer Lett (1983) 1.05
An additional 136 SSLP markers typed for the AXB and BXA recombinant inbred mouse strains. Mamm Genome (1997) 1.04
Additional evidence that the K-ras protooncogene is a candidate for the major mouse pulmonary adenoma susceptibility (Pas-1) gene. Exp Lung Res (1998) 1.03
Cancer chemopreventive activity of brassinin, a phytoalexin from cabbage. Carcinogenesis (1995) 1.02
Alternative splicing of the K-ras gene in mouse tissues and cell lines. Exp Lung Res (2001) 1.02
Heavy metal contamination and distribution in the urban environment of Guangzhou, SE China. Environ Geochem Health (2006) 1.01
Transplacental induction of pancreas tumors in hamsters by ethanol and the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res (1993) 1.01
The second intron of the K-ras gene contains regulatory elements associated with mouse lung tumor susceptibility. Proc Natl Acad Sci U S A (1994) 1.00
Mutational activation of the cellular Harvey ras oncogene in rat esophageal papillomas induced by methylbenzylnitrosamine. Cancer Res (1990) 1.00
Pervilleine A, a novel tropane alkaloid that reverses the multidrug-resistance phenotype. Cancer Res (2001) 1.00
Role of proto-oncogene activation in carcinogenesis. Environ Health Perspect (1992) 0.99
Metabolism of tobacco-specific N-nitrosamines by cultured human tissues. Proc Natl Acad Sci U S A (1983) 0.99
At least four loci and gender are associated with susceptibility to the chemical induction of lung adenomas in A/J x BALB/c mice. Genomics (1998) 0.98
The suppression of SH3BGRL is important for v-Rel-mediated transformation. Oncogene (2006) 0.98
Modulation of the multidrug-resistance phenotype by new tropane alkaloid aromatic esters from Erythroxylum pervillei. J Nat Prod (2001) 0.95
Dose-dependent ras mutation spectra in N-nitrosodiethylamine induced mouse liver tumors and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced mouse lung tumors. Carcinogenesis (1993) 0.94
Inhibition of lung tumourigenesis by sulindac: comparison of two experimental protocols. Carcinogenesis (1997) 0.93
Characterization and mapping of DNA damage induced by reactive metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) at nucleotide resolution in human genomic DNA. J Mol Biol (2001) 0.93
Comparative carcinogenicity in A/J mice and metabolism by cultured mouse peripheral lung of N'-nitrosonornicotine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, and their analogues. Cancer Res (1983) 0.91
Metabolism of tobacco-specific nitrosamines by cultured rat nasal mucosa. Cancer Res (1983) 0.91
A mouse model for tumor progression of lung cancer in ras and p53 transgenic mice. Oncogene (2006) 0.91
Optimal conditions to use Pfu exo(-) DNA polymerase for highly efficient ligation-mediated polymerase chain reaction protocols. Nucleic Acids Res (2001) 0.90
Homozygous codeletion and differential decreased expression of p15INK4b, p16INK4a-alpha and p16INK4a-beta in mouse lung tumor cells. Oncogene (1996) 0.90
5-Aza-2'-deoxycytidine is chemopreventive in a 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone-induced primary mouse lung tumor model. Carcinogenesis (1999) 0.90
Effects of NSAIDs on NNK-induced pulmonary and gastric tumorigenesis in A/J mice. Cancer Lett (1992) 0.89
Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung tumor formation by FGN-1 (sulindac sulfone). Carcinogenesis (1998) 0.89
Single nucleotide polymorphism (SNP) analysis of mouse quantitative trait loci for identification of candidate genes. J Med Genet (2004) 0.89
Inactivation of both Rb and p53 pathways in mouse lung epithelial cell lines. Exp Lung Res (2001) 0.88
K-ras mutations in lung tumors from A/J and A/J x TSG-p53 F1 mice treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and phenethyl isothiocyanate. Carcinogenesis (1995) 0.88
Immunomodulatory effects of the tobacco-specific carcinogen, NNK, on alveolar macrophages. Clin Exp Immunol (2003) 0.88
The induction of cyclooxygenase-1 by a tobacco carcinogen in U937 human macrophages is correlated to the activation of NF-kappaB. Carcinogenesis (2000) 0.87
Perinatal metabolism of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in C57BL mice. J Natl Cancer Inst (1984) 0.87
Comparative tumorigenicity and DNA methylation in F344 rats by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N-nitrosodimethylamine. Cancer Res (1986) 0.87
Entropy and distance of random graphs with application to structural pattern recognition. IEEE Trans Pattern Anal Mach Intell (1985) 0.87
DNA single-strand breaks and toxicity induced by 4-(methyl-nitrosamino)-1-(3- pyridyl)-1-butanone or N-nitrosodimethylamine in hamster and rat liver. Carcinogenesis (1994) 0.86
Deletion mapping of a putative tumor suppressor gene on chromosome 4 in mouse lung tumors. Cancer Res (1994) 0.85
Allelic loss of distal chromosome 4 in mouse lung tumors localize a putative tumor suppressor gene to a region homologous with human chromosome 1p36. Oncogene (1995) 0.85
Comparative carcinogenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N'-nitrosonornicotine in Syrian golden hamsters. Cancer Res (1981) 0.85
Treatment of human cells with N-Nitroso(acetoxymethyl)methylamine: distribution patterns of piperidine-sensitive DNA damage at the nucleotide level of resolution are related to the sequence context. Chem Res Toxicol (1999) 0.85
The intronic structure of cancer-related genes regulates susceptibility to cancer. Mol Carcinog (1994) 0.85
Use of p53 transgenic mice in the development of cancer models for multiple purposes. Exp Lung Res (2000) 0.85
Cdkn2a encodes functional variation of p16INK4a but not p19ARF, which confers selection in mouse lung tumorigenesis. Mol Carcinog (1999) 0.84
Metabolism and macromolecular interaction of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in cultured explants and epithelial cells of human buccal mucosa. Carcinogenesis (1993) 0.84
Quality of life among advanced breast cancer patients with and without distant metastasis. Eur J Cancer Care (Engl) (2012) 0.84
Chemopreventive effects of the aromatase inhibitor vorozole (R 83842) in the methylnitrosourea-induced mammary cancer model. Carcinogenesis (1998) 0.84
Inhibition of lung tumorigenesis by NSAIDS: a working hypothesis. Exp Lung Res (1998) 0.84
Genetic alterations in mouse lung tumors: implications for cancer chemoprevention. J Cell Biochem Suppl (1997) 0.83
Cyclin D1 as a proliferative marker regulating retinoblastoma phosphorylation in mouse lung epithelial cells. Cancer Lett (2001) 0.83
Biodistribution of ellagic acid and dose-related inhibition of lung tumorigenesis in A/J mice. Nutr Cancer (1992) 0.83
Chemopreventive efficacy of promising farnesyltransferase inhibitors. Exp Lung Res (2000) 0.83
Genetic variants cis-regulating Xrn2 expression contribute to the risk of spontaneous lung tumor. Oncogene (2009) 0.83
Bcl-2 and Bax are differentially expressed in hyperplastic, premalignant, and malignant lesions of mammary carcinogenesis. Cell Growth Differ (2000) 0.83
Effect of green tea on p53 mutation distribution in ultraviolet B radiation-induced mouse skin tumors. Carcinogenesis (1998) 0.83
Effects of chronic ethanol consumption on the metabolism and carcinogenicity of N'-nitrosonornicotine in F344 rats. Cancer Res (1984) 0.83
Tobacco-specific nitrosamines in Canadian cigarettes. J Cancer Res Clin Oncol (1990) 0.82
Strain A/J mouse lung adenoma growth patterns vary when induced by different carcinogens. Toxicol Pathol (1991) 0.82
Chemical carcinogenesis, mutagenesis, and teratogenesis. Can J Physiol Pharmacol (1996) 0.82
Tissue distribution of the tobacco-specific carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone and its metabolites in F344 rats. Cancer Res (1983) 0.82
Prevention of lung cancer progression by bexarotene in mouse models. Oncogene (2006) 0.81
Sequence variation and chromosomal mapping of the murine Cdkn2a tumor suppressor gene. Mamm Genome (1997) 0.81
Molecular evidence of Babesia caballi (Nuttall and Strickland, 1910) parasite transmission from experimentally-infected SCID mice to the ixodid tick, Haemaphysalis longicornis (Neuman, 1901). Vet Parasitol (2001) 0.81
Transplacental carcinogenicity of low doses of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone administered subcutaneously or intratracheally to hamsters. J Cancer Res Clin Oncol (1994) 0.81
Effects of nonsteroidal antiinflammatory drugs on oxidative pathways in A/J mice. Free Radic Biol Med (1995) 0.80
ras mutations in 2-acetylaminofluorene-induced lung and liver tumors from C3H/HeJ and (C3H x A/J)F1 mice. Cancer Res (1993) 0.80
Allele-specific activation and expression of the K-ras gene in hybrid mouse lung tumors induced by chemical carcinogens. Carcinogenesis (1994) 0.80
Transplacental genotoxicity of a tobacco-specific N-nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, in Syrian golden hamster. Mutat Res (1989) 0.80
Effects of alpha-deuterium substitution on the tumorigenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in F344 rats. Carcinogenesis (1987) 0.80
The tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is an active transplacental carcinogen in Syrian golden hamsters. Cancer Res (1990) 0.80
Assay of 1-nitropropane, 2-nitropropane, 1-azoxypropane and 2-azoxypropane for carcinogenicity by gavage in Sprague-Dawley rats. Carcinogenesis (1987) 0.80
Placental transfer of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone instilled intratracheally in Syrian golden hamsters. Cancer Res (1992) 0.80
Induction of COX expression by a tobacco carcinogen: implication in lung cancer chemoprevention. Inflamm Res (1999) 0.80
Alkylating agent and chromatin structure determine sequence context-dependent formation of alkylpurines. J Mol Biol (2001) 0.79
Single nucleotide polymorphism (SNP) analysis of mouse pulmonary adenoma susceptibility loci 1-4 for identification of candidate genes. J Med Genet (2003) 0.79
Metabolism and tissue distribution of tobacco-specific N-nitrosamines in the marmoset monkey (Callithrix jacchus). Carcinogenesis (1985) 0.79
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone modulation of cytokine release in U937 human macrophages. Cancer Immunol Immunother (2001) 0.79
Microautoradiographic localization of bound metabolites in the nasal cavities of F344 rats treated with the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. J Natl Cancer Inst (1985) 0.79
Anthropometry of Taiwanese women. Appl Ergon (1994) 0.79